Sfoglia per Autore
Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: Implications for cardiotoxicity of doxorubicin-taxane chemotherapies
2006-01-01 Salvatorelli, E; Menna, P; Cascegna, S; Liberi, A; Calafiore, Am; Gianni, L; Minotti, G
In vitro modelling of the structure-activity determinants of anthracycline cardiotoxicity.
2007-01-01 Menna, P.; Minotti, G; Salvatorelli, E.
Defective taxane stimulation of epirubicinol formation in the human heart: Insights into the cardiac tolerability of epirubicin-taxane chemotherapies
2007-01-01 Salvatorelli, E.; Menna, P.; Gianni, L.; Minotti, G
Doxorubicin degradation in cardiomyocytes
2007-01-01 Menna, P; Salvatorelli, E; Minotti, G.
Anthracycline cardiotoxicity in breast cancer patients: Synergism with trastuzumab and taxanes
2007-01-01 Gianni, L; Salvatorelli, E; Minotti, G
Anthracyclines
2008-01-01 Minotti, G; Salvatorelli, E; Menna, P
Increasing doxorubicin antitumor activity through COX-2 inhibition without increasing cardiotoxicity
2008-01-01 Bianch, F; Campiglio, M; Sasso, M; Ghirelli, C; Tagliabue, E; Cairo, G; Salvatorelli, E; Minotti, G; Menna, P; Menard, S
Anthracycline Cardiotoxicity
2008-01-01 Menna, P.; Salvatorelli, E.; Gianni, L.; Minotti, G
Cardiotoxicity of antitumor drugs
2008-01-01 Menna, P; Salvatorelli, E; Minotti, G
Tumor necrosis factor alpha and cardiomyocytes: evidence for a self-protective preconditioning
2009-01-01 Cacciapaglia, F.; Menna, P.; Salvatorelli, E.; Buzzulini, F.; Arcarese, L.; Margiotta, D.; Minotti, G; Afeltra, A.
Doxorubicinolone formation and efflux : A salvage pathway against epirubicin accumulation in human heart
2009-01-01 Salvatorelli, E; Menna, P; Lusini, M; Covino, E; Minotti, G
4’- Epidoxorubicin to reexplore anthracycline degradation in cardiomyocytes
2009-01-01 Menna, P; Salvatorelli, E; Minotti, G
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis
2010-01-01 Cacciapaglia, F.; Menna, P.; Navarini, L.; Salvatorelli, E.; Lo Vullo, M.; Vernuccio, A.; Minotti, G; Afeltra, A.
Pharmacological Foundation of Cardio-Oncology
2010-01-01 Minotti, G; Salvatorelli, E; Menna, P
The use of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients undergoing cytoreductive surgery (CS) for peritoneal carcinomatosis of ovarian origin
2010-01-01 De Tursi, M; Salvatorelli, E; Carella, C; Bianco, N; Massari, R; Sacco, R; Menna, P; Minotti, G; Iacobelli, S
Cardiovascular toxicity of antitumor drugs :Translating molecular mechanisms into clinical facts
2010-01-01 Menna, P.; Salvatorelli, E.; Salsano, C.; Gianni, L.; Minotti, G.
Translating molecular mechanisms into clinical facts
2010-01-01 Menna, P.; Salvatorelli, E.; Salsano, C.; Gianni, L.; Minotti, G
Anthracycline degradation in cardiomyocytes: a journey to oxidative survival
2010-01-01 Menna, P; Salvatorelli, E; Minotti, G
Minimal sampling colistin pharmacokinetics in critically ill patients
2011-01-01 Menna, P; Battistoni, F; Crea, F; Minotti, G; Salvatorelli, E; Dicuonzo, G
Pixantrone (PIX) Inhibition of Doxorubicinol (DOXOL) Formation in Human Myocardium: Implications for Cardiac Safety in Non-Hodgkin Lymphoma (NHL) Patients with Prior Anthracycline Treatment
2011-01-01 Salvatorelli, E.; Gonzalez Paz, O.; Covino, E.; Chello, M.; Singer, J.; Menna, P.; Minotti, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile